Clinical Process Services (CPS)
↗Dubai, United Arab Emirates
Clinical Process Services (CPS) is a leading regional Contract Research Organization (CRO) that provides end-to-end clinical research and regulatory solutions across the Middle East and North Africa (MENA). Headquartered in Dubai, the company specializes in helping global pharmaceutical, biotechnology, and medical device companies navigate the complex regulatory and clinical landscapes of the Arab world.
The company offers a wide range of services including clinical trial management (Phases I-IV), regulatory affairs, pharmacovigilance, medical writing, and market access strategies. CPS is known for its deep local expertise and its ability to accelerate drug registration and trial startup in key markets such as Saudi Arabia, the UAE, Egypt, and Jordan.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Revenue:$10M-$50M
Founded:2010
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, mAb, Vaccines, Cell & Gene Therapy
Active Trials:15
Trial Phases:Phase 1: 2 | Phase 2: 4 | Phase 3: 7 | Phase 4: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:CStone Pharmaceuticals (Regional clinical support), Pharmalink (Commercialization partner), Various GCC Health Authorities
COMPETITION
Position:Niche Player
Competitors:ClinServ, Accelsiors, PPD (Thermo Fisher), IQVIA (MENA Division), KazaCRO
LEADERSHIP
Key Executives:
Alvaro Serrano - Managing Director
LINKS
Website:cpsmena.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Clinical Process Services (CPS). The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.